News

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of February 16, 2020.

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A mass rabies exposure event in Utah in 2018 highlights the need for early recognition, public awareness and rapid public health response to the disease.

To evaluate the algorithm, the investigators looked at hospital encounters to determine trends in incidence and mortality from January 2011 through January 2019.

Concerns over the possibility of increased neural-tube defects and weight gain on dolutegravir are outweighed by the much lower rates of HIV transmission from mother to baby than are seen with efavirenz.

Investigators recently mapped out influenza and pneumonia cases among residents of long-term care facilities. They found distinct regional variations.

A new hexavalent combination vaccine for diphtheria, tetanus, pertussis, polio, hepatitis B, and Haemophilus influenzae type b won’t be commercially available in the United States before 2021, but the CDC has issued guidance for use of the vaccine in infants.

Studies have shown that human coronaviruses can survive for days on certain surfaces. What does this mean for infection prevention efforts?

System hospitals are proactive in reducing incidence of C diff infections and CLABSIs, according to study in JAMA Network Open.

The new C diff strain may turn out to be particularly severe and requires sufficient monitoring.

Infectious diseases consultations during hospital stays were associated with improved outcomes after discharge in patients with S aureus bacteremia for at least 5 years.

The CDC’s plan for testing patients with flu for coronavirus will inform their response strategy, should the infection spread, the agency said.

The Advisory Committee on Immunization Practices has announced changes to the 2020 child and adolescent vaccine schedule.

The NIH has begun the first clinical trial evaluating the safety of a monthly dapivirine ring used to prevent HIV among pregnant women in eastern and southern Africa.

A commentary agrees with World Health Organization recommendations against routine use of corticosteroids in treatment of COVID-19.

A new study has identified that misinformation and limited clinician communication around HPV risk among young men who have sex with men some of the barriers to HPV vaccination.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of February 9, 2020.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Pneumococcal conjugate vaccines have been effective at reducing pneumonia, sepsis, and bacteremia in immunized populations. Pneumococcal meningitis, however, remains a significant challenge.

People living with HIV who don’t receive early intervention and primary care end up with a disproportionate share of health care costs, according to a new study that examined barriers to care and costs at a Dublin hospital.

Social and biological factors increase the risk of respiratory failure and death in vulnerable pre-term infants, a new study shows.

PWID are unlikely to receive testing for HIV and hepatitis C, according to a new study that found that 8.5% were tested for HIV and 7.7% were tested for HCV within 1 year of a clinical encounter consistent with injection drug use.

A new study found that the Zoster Vaccine Live not only reduced the risk for shingles but also reduced stroke risk by 16% in older adults.

The rising price of antiretroviral therapy for people living with HIV in the United States is a barrier to adherence. It also blunts efforts to achieve higher rates of viral suppression.

The International Health Regulations Emergency Committee decided today that the Ebola outbreak in the Democratic Republic of the Congo remains a PHEIC.

In a scenario where health care preparedness is key, what are the best strategies for US hospitals to pursue?